Fairmount Funds Management LLC
Source: SEC Form 13F · as of Mar 2026Fairmount Funds Management LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $1.37B in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$1.37B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Damora Therapeutics, Inc. (DMRA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| DMRADamora Therapeutics, Inc. | 8,713,000 | $225.7M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 2,537,191 | $212.9M |
| COGTCogent Biosciences, Inc. | 5,503,418 | $211.8M |
| SYRESpyre Therapeutics, Inc. | 4,018,101 | $202.7M |
| ORKAOruka Therapeutics, Inc. | 3,705,262 | $181.7M |
| VRDNViridian Therapeutics, Inc.\DE | 3,914,458 | $76.6M |
| ELVNEnliven Therapeutics, Inc. | 1,855,644 | $72.7M |
| JBIOJade Biosciences, Inc. | 4,553,494 | $64.0M |
| CBIOCRESCENT BIOPHARMA, INC. | 2,747,866 | $50.5M |
| ZBIOZenas BioPharma, Inc. | 2,359,025 | $46.1M |
| APGEApogee Therapeutics, Inc. | 298,647 | $25.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.